Hormone Receptor Positive Tumor Recruiting Phase 0 Trials for Denosumab (DB06643)

IndicationStatusPhase
DBCOND0075370 (Hormone Receptor Positive Tumor)Recruiting0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03691311Biomarker Study of the Antitumoral Activity of Denosumab in the Pre- Operative Setting of Early Breast CancerTreatment